UK and Ireland market - Dedalus to transition customers to next generation of ORBIS EPR to accelerate their digitisation journey
Dedalus Group has announced that ORBIS U will be its strategic EPR clinicals solution for the UK and Ireland market.
Dedalus Group has announced that ORBIS U will be its strategic EPR clinicals solution for the UK and Ireland market.
As a result of this decision, we will be commencing to plan the upgrade of existing Lorenzo clinicals customers to the ORBIS U platform and launching the ORBIS U product in the UKI market.
We will be retaining the Lorenzo Care Manager module for the new solution and integrating ORBIS U with our other UKI PAS solutions. We believe, for all our current Lorenzo and PAS customers, implementing ORBIS U clinicals will offer the most rapid, highest value and lowest risk approach to deliver a full EPR platform within their Trust and across an ICS.